Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Preclinical evaluation of Sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases

Figure 1

Size of osteolytic lesions (mm 2 ) in nude mice with bone metastases. Osteolytic lesions were analysed by plain radiography 5 weeks following tumor cell inoculation; Control (n = 7), Sunitinib (n = 7). Box plot shows 25–75 percentiles, whiskers 05–95 percentiles,+ indicates mean and line indicates median. Significance was determined by 2-tailed Student t-test (*p < 0.05, op < 0.1). No difference is observed in the size of osteolytic lesions with Sunitinib therapy (mean ± SD: Ctrl 0.65 ± 0.33; Sunitinib 0.59 ±0.35).

Back to article page